Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients

被引：0

作者：

Daphne SC Lee

Sook-Yee Yoon

Lai Meng Looi

Peter Kang

In Nee Kang

Kavitta Sivanandan

Hany Ariffin

Meow Keong Thong

Kin Fah Chin

Nur Aishah Mohd Taib

Cheng-Har Yip

Soo-Hwang Teo

机构：

[1] Sime Darby Medical Centre,Cancer Research Initiatives Foundation

[2] University Malaya Medical Centre,Department of Pathology

[3] University Malaya,Department of Paediatrics

[4] University Malaya Cancer Research Institute,Department of Surgery

[5] University Malaya Medical Centre,undefined

[6] University Malaya,undefined

[7] University Malaya Medical Centre,undefined

[8] University Malaya,undefined

[9] University Malaya Medical Centre,undefined

[10] University Malaya,undefined

来源：

Breast Cancer Research | / 14卷

关键词：

Breast Cancer; TP53 Mutation; Contralateral Breast Cancer; Germline TP53 Mutation; TP53 Mutation Carrier;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations
Brunet, J.
Gutlerrez-Enriquez, S.
Torres, A.
Berez, V.
Sanjose, S.
Galceran, J.
Izquierdo, A.
Menendez, J. A.
Guma, J.
Borras, J.
CLINICAL GENETICS, 2008, 73 (05) : 465 - 473
[42] Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany
Hamann, U
Liu, X
Bungardt, N
Ulmer, HU
Bastert, G
Sinn, HP
EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (06) : 464 - 467
[43] Observed germline BRCA1/2 and TP53 tumor genomic profiling allele frequencies
Wheeler, Rebecca
Terhaar, Catherine
Kruzel, Mark
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[44] Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
Lazzari, Grazia
Buono, Giuseppe
Zannino, Benedetto
Silvano, Giovanni
BREAST CANCER-TARGETS AND THERAPY, 2021, 13 : 299 - 310
[45] SPECTRUM OF BRCA1, BRCA2, PALB2, ATM AND TP53 PATHOGENIC VARIANTS IN BREAST AND OVARIAN CANCER PATIENTS OF TATAR AND BASHKIR ETHNIC ORIGIN
Imyanitov, Evgeny
Bakayeva, Elvina
Sultanbayev, Alexandr
Faiskhanova, Raniya
Mukhamediarova, Gulnara
Fatikhova, Alfiya
Askarov, Vadim
Venina, Aigul
Romanko, Alexandr
Sokolenko, Anna
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A368 - A368
[46] The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients
Saleem, Mohamed
Ghazali, Mohd Bazli
Wahab, Md Azlan Mohamed Abdul
Yusoff, Narazah Mohd
Mahsin, Hakimah
Seng, Ch'ng Ewe
Khalid, Imran Abdul
Rahman, Mohd Nor Gohar
Yahaya, Badrul Hisham
CANCER BIOLOGY AND ADVANCES IN TREATMENT, 2020, 1292 : 1 - 12
[47] Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
Peto, J
Collins, N
Barfoot, R
Seal, S
Warren, W
Rahman, N
Easton, DF
Evans, C
Deacon, J
Stratton, MR
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) : 943 - 949
[48] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
Cherbal, Farid
Bakour, Rabah
Adane, Saida
Boualga, Kada
Benais-Pont, Gaelle
Maillet, Philippe
DISEASE MARKERS, 2010, 28 (06) : 377 - 384
[49] Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
Palmero, Edenir Inez
Alemar, Barbara
Schuler-Faccini, Lavnia
Hainaut, Pierre
Moreira-Filho, Carlos Alberto
Ewald, Ingrid Petroni
dos Santos, Patricia Koehler
Izetti Ribeiro, Patricia Lisboa
de Oliveira Netto, Cristina Brinkmann
Kelm, Florence Le Calvez
Tavtigian, Sean
Cossio, Silvia Liliana
Giugliani, Roberto
Caleffi, Maira
Ashton-Prolla, Patricia
GENETICS AND MOLECULAR BIOLOGY, 2016, 39 (02) : 210 - 222
[50] Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women
Querzoli, P
Albonico, G
di Iasio, MG
Ferretti, S
Rinaldi, R
Cariello, A
Pedriali, M
Matteuzzi, M
Maestri, I
Nenci, I
BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (02) : 135 - 142

← 1 2 3 4 5 →